Cambridge Investment Research Advisors »

Eledon Pharmaceuticals shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Eledon Pharmaceuticals (ELDN) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Eledon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eledon Pharmaceuticals held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eledon Pharmaceuticals by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $148k 48k 3.07

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Microsoft Corp Com (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Alphabet Inc Cap Stk Cl A (GOOGL)
Alphabet Inc Cap Stk Cl C (GOOG)
SPDR Gold Tr Gold Shs (GLD)

View all positions for Cambridge Investment Research Advisors

Top funds holding Eledon Pharmaceuticals

BVF
BlackRock
Vanguard Group
Defilade Capital Management
Vanguard Capital Management
Ensign Peak Advisors
Blue Owl Capital Holdings
Zimmer Partners
Geode Capital Management
Sphera Funds Management
Catalio Capital Management
AWM Investment Company
Leucadia National Corporation
Kingdon Capital Management
ADAR1 Capital Management

View all funds holding Eledon Pharmaceuticals